LTBR and autoimmune disease: The lymphotoxin-beta receptor (LTBR) pathway has been associated with the appearance of ELSs at sites of chronic inflammation in a variety of autoimmune diseases, and has been shown to regulate the expression levels of CXCL13, CCL19, and PNAd (122, 123).